RELATED APPLICATIONS
BACKGROUND OF THE INVENTION
[0002] The present invention relates generally to addressing problems related to the digestive
system, particularly obesity and type II diabetes. Additionally, it is contemplated
that the methods and devices of the present invention may be used in treating other
digestive conditions such as benign or malignant obstructions of the stomach, small
bowel and/or colon when clinically indicated; peptic ulcer disease; inflammatory bowel
disease; adhesions; annular pancreas; duodenal, pancreatic, intestinal, or colonic
primary malignancies; and secondary malignancies.
Obesity
[0003] According to the Center for Disease Control (CDC), sixty six percent of the United
States population are overweight, and thirty two percent are obese, presenting an
overwhelming health problem. From an economic standpoint, it is estimated that more
than 100 billion dollars are spent on obesity and treating its major co-morbidities.
This figure does not include psychological and social costs. Many health care experts
consider obesity the largest health problem facing westernized societies and consider
obesity an epidemic. From a medical standpoint, obesity is the primary risk factor
for type 2 diabetes and obstructive sleep apnea. It increases the chances for heart
disease, pulmonary disease, infertility, osteoarthritis, cholecystitis and several
major cancers, including breast and colon cancers. Despite these alarming facts, treatment
options for obesity remain limited.
[0004] Treatment options include dietary modification, very low-calorie liquid diets, pharmaceutical
agents, counseling, exercise programs and surgery. Diet and exercise plans often fail
because most individuals do not have the discipline to adhere to such plans. When
diet and exercise fail, many try dietary supplements and drugs or other ingestible
preparations promoted as being capable of suppressing appetite or inducing satiety.
In general, these techniques for treating compulsive overeating/obesity have tended
to produce only a temporary effect. The individual usually becomes discouraged and/or
depressed after the initial rate of weight loss plateaus and further weight loss becomes
harder to achieve. The individual then typically reverts to the previous behavior
of compulsive overeating.
[0005] Surgical procedures that restrict the size of the stomach and/or bypass parts of
the intestine are the only remedies that provide lasting weight loss for the majority
of morbidly obese individuals. Surgical procedures for morbid obesity are becoming
more common based on long-term successful weight loss result.
[0006] Bariatric surgery is a treatment for morbid obesity that involves alteration of a
patient's digestive tract to encourage weight loss and to help maintain normal weight.
Known bariatric surgery procedures include jejuno-ileal bypass, jejuno-colic shunt,
biliopancreatic diversion, gastric bypass, Roux-en-Y gastric bypass, gastroplasty,
gastric banding, vertical banded gastroplasty, and silastic ring gastroplasty. A more
complete history of bariatric surgery can be found on the website of the American
Society for Bariatric Surgery at
http://www.asmbs.org, the contents of which are incorporated by reference herein in their entirety.
[0007] The surgeries which create malabsorption, such as the by-pass operations, although
effective in weight reduction, involve permanent modification of the GI tract and
have a risk of short and long term complication and even death.
[0008] Gastric bypass is the most common weight loss operation in the United States. This
procedure reduces the size of the stomach and shortens the effective-length of intestine
available for nutrient absorption. With gastric bypass many investigators have reported
weight loss results that exceed 70% of excess weight. However, this efficacy does
not come without complication. The accepted mortality of the procedure is 1 in 200.
Additionally, because various sections of the intestine are responsible for absorbing
various nutrients from the chyme being digested, bypassing sections of the intestine
can result in an inability of the modified digestive tract to benefit from certain
nutrients. In certain cases, this results in conditions such as anemia and must be
treated with high doses of vitamin or nutrient supplements.
Diabetes
[0009] According to the National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) an estimated 20.8 million people in the United States, 7.0 percent of the
population, have diabetes, a serious, lifelong condition. Of those, 14.6 million have
been diagnosed, and 6.2 million have not yet been diagnosed. In 2005, about 1.5 million
people aged 20 or older were diagnosed with diabetes. According to the American Diabetes
Association, the total annual economic cost of diabetes in 2002 was estimated to be
$132 billion.
[0010] Diabetes is a set of related diseases in which the body cannot regulate the amount
of sugar (glucose) in the blood. Glucose in the blood provides the body with energy.
In a healthy person, the blood glucose level is regulated by several hormones including
insulin, glucagons, and epinephrine. Insulin is produced by the pancreas, a small
organ near the stomach that also secretes important enzymes that help in the digestion
of food. Insulin allows glucose to move from the blood into the liver, muscle, and
fat cells, where it is used for fuel.
[0011] At least 90% of patients with diabetes have Type 2 diabetes wherein the pancreas
secretes insulin but the body is partially or completely unable to use the insulin.
This is sometimes referred to as insulin resistance. The body tries to overcome this
resistance by secreting more and more insulin. People with insulin resistance develop
Type 2 diabetes when they do not continue to secrete enough insulin to cope with the
higher demands.
[0012] Recently, evidence for reduction of complications of type 2 diabetes with tight control
of hyperglycemia has been reported, but current therapies, including diet, exercise,
behavior modification, oral hypoglycemic agents, and insulin, rarely return patients
to euglycemia.
[0013] For reasons not completely known, the majority of patients who undergo gastric bypass
surgery experience resolution of Type 2 diabetes and enjoy normal blood glucose and
glycosylated hemoglobin levels with discontinuation of all diabetes-related medications.
One hypothesis, that has been proposed, is that diabetes control results from the
expedited delivery of nutrient-rich chyme (partially digested food) to the distal
intestines, enhancing a physiologic signal that improves glucose metabolism, the so
called "hindgut hypothesis". However, because gastric bypass surgery is considered
a relatively high-risk major surgery, it is not used to treat Type 2 diabetes.
OBJECTS AND SUMMARY OF THE INVENTION
[0014] The methods and devices of the present invention are primarily directed to a minimally
invasive, endoscopic solution for treating patients with obesity and/or Type 2 diabetes.
The methods and devices can also be of benefit in laparoscopic and open surgical procedures.
The solution is simple, user-friendly, reversible, and does not require a permanent
implant. When the procedure is performed endoscopically, the need for abdominal incisions
is eliminated. Thus, the procedure has the potential of being performed outside of
the operating room, potentially in an endoscopy suite.
[0015] One aspect of the present invention treats the aforementioned conditions by creating
a partial bypass of a portion of the small intestines. Preferably, an anastomosis
is created between the distal portion of the second section and/or third section of
the duodenum and the ileum or colon. Using anatomical landmarks as reference, the
anastomosis should preferably be positioned in the duodenum distal to the hepatopancreatic
ampulla where the common bile and main pancreatic duct empty into the duodenum and
proximal to the point where the superior mesenteric artery and vein cross over the
duodenum.
[0016] This solution creates an alternative pathway for chyme. A portion of the nutrients
will bypass a portion of the small intestines and thus not be absorbed (controlled
absorption). The amount of bypass is controlled by the size of the anastomosis. The
physician is thus able to vary the size of the anastomosis both at the time of the
procedure and during subsequent follow-up procedures. The anastomosis also provides
a bypass for nutrient-rich chyme to enter the ileum or colon. This is thought to have
the effect of triggering early satiety as well as improving glucose metabolism. A
potential candidate mediator of this effect is glucagon-like peptide 1 (GLP-1). This
incretin hormone is secreted by cells in the distal bowel in response to nutrients,
which stimulates insulin secretion.
[0017] Another aspect of the present invention provides a method by which an endoscope is
inserted orally and advanced through the upper GI track and then into the duodenum.
Another endoscope is inserted anally and advanced into the colon or ileum. The normal
anatomy in a human is such that the second and third sections of the duodenum are
in close proximity with portions of the ileum and colon. If either structure is illuminated
from within, it can readily be seen from the other. For example, if the duodenum is
illuminated, the light can be seen with an endoscope in the ileum or colon and the
ileum or colon can then be gently maneuvered such that it is touching the duodenum.
The ileum or colon can also be positioned by visualizing the endoscopes using fluoroscopic
imaging and maneuvering the endoscope within the ileum or colon to close proximity
of the endoscope in the duodenum.
[0018] Once intimate contact has been confirmed between the duodenum and the ileum or colon,
magnets that have been pre-attached to the endoscope are coupled. In another embodiment
of the invention magnets are passed through the working channel of the endoscope rather
than pre-attached. Once the magnets have been magnetically coupled and alignment is
verified utilizing endoscopic and/or fluoroscopic imaging, they are released from
the endoscopes. The two coupled magnets create intimate contact between the serosal
surfaces of the two vessels. During the healing period the tissue between the magnets
is compressed and becomes necrotic. The tissue near the outside of the anastomosis
device is compressed at a lower force. This tissue forms a region or ring of healed
tissue. After a few weeks the necrotic tissue, along with the magnetic implants detach
and are expelled. There is no flow between vessels during the healing period. Everything
flows through the natural distal duodenum and thus there is no risk of obstructing
flow. Human serosal tissue that is placed in intimate contact has been shown to heal
within 7 days.
[0019] Patients can be tracked and if absorption needs to be further limited a follow up
procedure can be performed to create additional anastomosis in the same or other locations
or make the anastomosis larger. Likewise, if the anastomosis is too large, it may
be modified by closing a portion of the anastomosis with an endoluminal suturing,
stapling, or clip device. The procedure may be completely reversed by closing the
entire anastomoisis with such devices.
BRIEF DESCRIPTION OF THE DRAWINGS
[0020]
Figs 1-5 are views of the digestive system showing a progression of steps of an embodiment
of a method of the present invention for creating a duodenum to colon anastomosis;
Fig. 6 is a partial view of the digestive system with an anastomosis formed by an
embodiment of a method of the present invention;
Figs 7-10 are views of the digestive system showing a progression of steps of an embodiment
of a method of the present invention for creating a partial bypass with a side-to-side
anastomosis between the duodenum and ileum;
Fig. 11a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 11b is a perspective view of the device of Fig. 11a being released from the delivery
device of Fig. 11a;
Fig. 12a is an end view of an embodiment of a device of the present invention attached
to an embodiment of a delivery device of the present invention;
Fig. 12b is a section view taken along lines A-A of Fig. 12a;
Fig. 13 is a plan view of an embodiment of a device of the present invention attached
to an embodiment of a delivery device of the present invention;
Fig. 14 is an elevation of an embodiment of a device of the present invention attached
to an embodiment of a delivery device of the present invention;
Fig. 15 is a side elevation of a pair of devices of an embodiment of the present invention
being implanted in adjacent body lumens to form an anastomosis therebetween;
Fig. 16a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 16b is a perspective view of the device of Fig. 16a being advanced from a distal
end of the delivery device of Fig. 16a;
Fig. 16c is a perspective view of the device of Fig. 16a being released from the delivery
device of Fig. 16a;
Fig. 17a is an end view of an embodiment of a device of the present invention attached
to an embodiment of a delivery device of the present invention;
Fig. 17b is a section view taken along lines B-B of Fig. 17a;
Fig. 18a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 18b is a perspective view of the device of Fig. 18a being advanced from a distal
end of the delivery device of Fig. 18a;
Fig. 18c is a perspective view of the device of Fig. 18a being released from the delivery
device of Fig. 18a;
Fig. 19 is a detail view of area A of Fig. 18b;
Fig. 20 is a detail view of area B of Fig. 18c;
Fig. 21a is an end view of an embodiment of a device of the present invention attached
to an embodiment of a delivery device of the present invention;
Fig. 21b is a section view taken along lines C-C of Fig. 21a;
Fig. 21c is a section view taken along lines D-D of Fig. 21a;
Fig. 22 is a cutaway view of an embodiment of a device of the present invention loaded
into an embodiment of a delivery device of the present invention;
Fig. 23a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 23b is a perspective view of the device of Fig. 23a being released from the delivery
device of Fig. 23a;
Fig. 24a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 24b is a perspective view of the device of Fig. 24a being advanced from a distal
end of the delivery device of Fig. 24a;
Fig. 24c is a perspective view of the device of Fig. 24a being released from the delivery
device of Fig. 24a;
Fig. 24d is a detail view of area C of Fig. 24c;
Fig. 25 is a comparison of device shapes and resulting anastomosis shapes.
Fig. 26 is a perspective view of an embodiment of a delivery device of the present
invention being used to deliver an arrangement of two devices according to an embodiment
of the present invention;
Fig. 27 is a perspective view of an embodiment of a delivery device of the present
invention being used to deliver an arrangement of two devices according to an embodiment
of the present invention;
Fig. 28 is a perspective view of an embodiment of a delivery device of the present
invention being used to deliver an arrangement of four devices according to an embodiment
of the present invention;
Figs. 29a-d are a progression of perspective views of an embodiment of a delivery
device of the present invention releasing an embodiment of a device of the present
invention;
Fig. 30a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 30b is a perspective view of the device of Fig. 30a being advanced from a distal
end of the delivery device of Fig. 30a;
Fig. 30c is a perspective view of the device of Fig. 30a being released from the delivery
device of Fig. 30a;
Fig. 31a is a perspective view of an embodiment of a device of the present invention
attached to an embodiment of a delivery device of the present invention;
Fig. 31b is a perspective view of the device of Fig. 31a being advanced from a distal
end of the delivery device of Fig. 31a;
Fig. 31c is a perspective view of the device of Fig. 31a being released from the delivery
device of Fig. 31a;
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0021] The invention provides for the method and device apparatus to create a partial bypass
between the duodenum and ileum or duodenum and colon utilizing a completely incisionless
endoscopic method using both the mouth and anus as natural pathways for gaining access
to the preferred anastomosis location. An important aspect of the invention is that
the anastomosis is created between naturally adjacent or close proximity sections
of the duodenum and ileum or duodenum and colon, therefore allowing a means for a
totally incisionless procedure. The invention generally involves inserting a first
endoscopic delivery device orally into the duodenum. A similar second endoscopic delivery
device is inserted anally into the colon or the ileum to a position where the tracts
of the ileum or colon naturally lie adjacent or in close proximity to the duodenum.
Having been pre-assembled at the distal tip of the endoscopic delivery device or advanced
through a channel of the endoscope or overtube, the magnetic implants are subsequently
aligned and magnetically coupled. The implant devices are magnetically attracted to
each other (one or both being magnets) and are aligned to one another using visual
and/or fluoroscopic guidance and released from their respective deployment devices.
The magnetic implants apply force to the vessel walls trapped between them and pressure
necrosis preferably results within a few weeks. The circumferential tissue near the
edge of the magnetic devices is of lower pressure and creates a healed continuous
region of tissue between the vessels. After an appropriate period of time, the coupled
magnetic devices and compressed necrotic tissue detach from the surrounding tissue
therefore creating an anastomosis. Subsequently, the magnetic implants pass through
the digestive tract leaving no permanent implant in the body. A first series of device
embodiments of the invention illustrate using magnetic implants that are pre-assembled
to the distal tip of the endoscope. A second series of embodiments of the invention
illustrates using magnetic implants that are advanced through the working channel
of an endoscope instead of pre-assembled at the distal tip. A third series of embodiments
illustrates releasably attaching the magnetic devices to an overtube that surrounds
the endoscope as well as advancing the devices through a lumen within the wall of
an overtube.
[0022] As shown in Fig. 1, the digestive tract 10 includes the esophagus 12, which empties
into the stomach 14. Distal to the stomach is the small intestine, which is comprised
of the duodenum 16, jejunum 18, and ileum 20 sections. The ileum 20 empties into a
part of the colon 22 called the cecum. The colon generally consists of five main segments:
ascending 22a, transverse 22b, descending 22c, sigmoid 22d, and rectum 22e.
[0023] Fig. 6 shows the various segments of the duodenum and anatomical landmarks within
and around the duodenum. The duodenum consists of four segments: superior 16a, descending
16b, horizontal 16c, and ascending 16d. In this figure, a section of the transverse
colon has been removed to view the anatomical landmarks near the duodenum more clearly.
Generally, the common bile and pancreatic ducts combine into the hepatopancreatic
ampulla 24 which empties into the descending duodenum 16b approximately two-thirds
along its length. The superior mesenteric artery and vein 26 cross the horizontal
duodenum segment 16c at its distal end.
[0024] Although an anastomosis could be made anywhere in the duodenum to the ileum or colon,
the preferred duodenal location for the anastomosis 28 is in the distal third of the
descending segment 16b and/or the horizontal segment 16c of the duodenum, provided
that the anastomosis is distal to the hepatopancreatic ampulla 24 and proximal of
the superior mesenteric artery and vein 26. Creating the anastomosis distal to the
common bile and pancreatic ducts will allow their contents to flow in the newly created
partial bypass as well as in the original natural tract. Positioning the anastomosis
proximal of the supererior mesenteric artery and vein provides many benefits: 1) access
is easier than going more distal, 2) the malabsorptive effect will be enhanced from
bypassing the duodenum more proximally, 3) the position is ideal for connecting the
duodenum to naturally adjacent segments of the colon and ileum, and 4) connecting
proximal of the superior mesenteric artery and vein avoids potential complications
of placing devices on or directly adjacent the wall of the superior mesenteric artery
and vein.
[0025] Referring to Figs. 1 and 6 for the duodenum to colon side-to-side anastomosis, the
invention takes into account that the transverse colon 22b naturally lies on top of
(superior) the preferred location in the duodenum 28 as described above, in which,
the superior wall of the duodenum is adjacent the posterior wall of the transverse
colon 22b. Creating an anastomosis between naturally adjacent tracts simplifies the
procedure of accessing the anastomosis sites and aligning the anastomosis devices
into correct position. This is especially evident for a duodenum to transverse colon
anastomosis as it is of common practice and skill level for endoscopists to access
these locations in the digestive tract. Although advanced access tools such as single
or double balloon enteroscopy may be used, this anastomosis location allows the use
of standard endoscopic devices to access the duodenum and transverse colon.
[0026] A first endoscopic delivery device 30a is inserted orally and advanced through the
esophagus 12, stomach 14, and into the duodenum 16. The endoscopic delivery device
30a consists of a pre-assembled endoscope 32a, delivery catheter 34a, and magnetic
implant 36a. The magnetic implant 32a is releasably attached to the distal tip of
the delivery catheter 34a which has been loaded into a working channel of the endoscope
32a.
[0027] Similarly, a second endoscopic delivery device 30b is inserted through the anus 22f
and advanced into the transverse colon 22b. In similar fashion, the endoscopic delivery
device 30b consists of a pre-assembled endoscope 32b, delivery catheter 34b, and magnetic
implant 36b. The magnetic implant 32b is releasably attached to the distal tip of
the delivery catheter 34b which has been loaded into a working channel of the endoscope
32a.
[0028] Once the first 30a and second 30b endoscopic delivery devices are roughly positioned
into the duodenum 16 and transverse colon 22b as shown in Fig. 1, the operator should
confirm that the endoscopes are in adjacent vessels with close proximity. This may
be accomplished by visualizing the light source emitted from the first endoscope by
the second endoscope. For example, the light source emitted by the endoscope 32a in
the duodenum 16 should be easily viewed by the endoscope 32b in the transverse colon
22b and vise-versa. Additionally, or instead of the light source, the position of
the first endoscope to the second may be verified by visualizing the first endoscope
touching and moving the wall of the vessel of the second endoscope. For example, the
first endoscope 32a in the duodenum 16 may be articulated to touch and displace the
wall of both the duodenum and the adjacent wall of the transverse colon. The second
endoscope in the transverse colon 22b would view the resulting wall motion to confirm
the proximity of the first endoscope in the duodenum. An additional and preferred
method of confirming that the endoscopes are in adjacent vessels of close proximity
is to use fluoroscopy to confirm the position and aid in guiding the magnetic implants
into their final coupled position. For example, if the distal end of the roughly positioned
endoscopic delivery device 30a in the duodenum 16 is not in close proximity and adjacent
to the distal end of the endoscopic delivery device 30b in the transverse colon 22b,
fluoroscopy may be used to articulate the distal tip of the endoscopic delivery devices
and their respective vessels into final position. This is accomplished by manipulating
and articulating the endoscopes 32a and 32b, the delivery catheters 34a and 34b, and/or
the magnetic implant 36a and 36b. The delivery catheter 34 is designed to move axially
within the working channel of the endoscope 32 and may also be designed so that its
distal tip may articulate the attached magnetic implant 36. The magnetic implant 36
may be positioned axially or radially by advancing or rotating the delivery catheter
34 relative to the endoscope 32. Contrast may be injected into the duodenum 16 and
transverse colon 22b during fluoroscopy to visualize the vessels and help bring them
into proximity to one another by articulating and manipulating the devices. Once brought
into close proximity, the magnetic implants will couple and self align as shown in
Fig. 2. Once coupled, the magnetic implant in the duodenum should be visually inspected
to make sure it is in the preferred position 28 as described previously and shown
in Fig. 6. Additionally, fluoroscopy may be used to verify that the magnetic implants
are properly oriented and contrast may be injected to show that the vessels remain
adjacent and are not adversely twisted. If the magnetic implants are not properly
aligned or the vessel wall has been adversely deformed, the magnetic implants may
be pulled apart and repositioned using the same techniques as described above. Once
the operator is satisfied with the positioning of the magnetic implants and vessel
geometry, the coupled magnetic implants 36a and 36b are released from their respective
delivery catheters 34a and 34b and the endoscopic delivery devices are removed from
the body. If the implants need to be repositioned or removed after release, it is
preferable that the implants could be easily recaptured using the same endoscopic
delivery devices.
[0029] Fig. 3 shows a lateral view of Fig. 2 of the coupled magnetic implants 36a and 36b
after they have been released from the delivery catheters 34a and 34b. The magnetic
implants 36a and 36b compress the duodenal and colon wall between them which results
in ischemic pressure necrosis of the tissue trapped between them. The surrounding
circumferential tissue is compressed at a lower force and results in a healed continuous
region or ring of tissue between the vessels around the magnetic implants. After an
appropriate period of time, the coupled magnetic implants and compressed necrotic
tissue detach from the surrounding tissue and therefore create an anastomosis. Once
detached, the implants pass through the digestive tract, leaving no device in the
body. Fig. 4 illustrates the anastomosis after the magnetic implants have detached
from the surrounding tissue and are about to start their journey out of the digestive
tract. Fig. 5 shows the preferable path the magnetic implants take to be eliminated
from the digestive tract. No permanent implant is left in the body. Although not ideal,
the magnetic implants may start their journey by traveling down the duodenum instead
of the colon side of the anastomosis. This may take longer for the implants to exit
the body as they are taking a longer pathway. It is also contemplated that if they
initially started down the duodenum (long path) that once they reach the colon side
of the anastomosis that they could pass through the anastomosis and travel down the
duodenum side a second time.
[0030] Notice in Fig. 4 and Fig. 5 the resulting anastomosis creates a partial bypass where
chyme may take one of two paths: 1) the original natural path through the duodenum
and on to the jejunum or 2) the new path created with the anastomosis to the transverse
colon 22b. It is the object of this invention to leave the original natural path in
place so that chyme, bile, and other digestive juices may travel down both paths.
Chyme that takes the new path will bypass a portion of the small intestines and therefore
not be absorbed. The ratio of chyme going through the new path may be dependent on
the size of the anastomosis relative to the original vessel size. The size of the
anastomosis may be tailored by the physician at the time of the procedure and during
subsequent follow-up procedures. For example, if the first anastomosis was not large
enough to create the desired effect, the physician could enlarge the first anastomosis
with another device or create a second anastomosis preferably after the first anastomosis
device had exited the body. Alternatively, if the first anastomosis was too large
or the procedure needed to be reversed, the physician could partially or completely
close the anastomosis with a transluminal suturing, stapling, or clip device. The
anastomosis also provides a bypass for nutrient-rich chyme to enter the ileum or colon.
This is thought to have the effect of triggering early satiety as well as improving
glucose metabolism. A potential candidate mediator of this effect is glucagon-like
peptide 1 (GLP-1). This incretin hormone is secreted by cells in the distal bowel
in response to nutrients, which stimulates insulin secretion.
[0031] The present invention also contemplates a duodenum to ileum anastomosis, taking into
account that a portion of the ileum 20 naturally lies adjacent or in close proximity
to the preferred location in the duodenum 28 as described above. Although the ileum
is a more difficult region to access than the transverse colon from the large intestines,
using adjacent tracts will simplify locating and aligning the duodenum and ileum vessels
and magnetic anastomosis devices to one another. Advanced access tools such as single
and double balloon enteroscopy devices may be used to access this location. It is
preferable that an anastomosis device and delivery system work in conjunction with
advanced access tools and techniques.
[0032] It should also be noted that use of the term "adjacent to" or "in close proximity
to" as used herein accounts for anatomical variations, which may account for a separation
of up to a few inches. It is well within the scope of the present invention to use
the distal ends of the probes/endoscopes to move the digestive tract slightly to establish
a magnetic connection. Notably, unlike prior art references that puncture the digestive
tract with additional probes in order to manipulate anatomy while establishing connections
(see e.g.
U.S. Patent Publication 2008/0208224 to Surti et al.), the devices and methods of the present invention have been found to easily manipulate
portions of the digestive tract significant distances by simply advancing the probes/endoscopes
into the lumen walls of the bowels. Hence, it is contemplated that the present invention
encompasses doing so, preferably without making a single incision or puncture through
patient tissue.
[0033] Figs. 7-10 show in stepwise fashion an incisionless method for creating a partial
bypass with a side-to-side anastomosis between the duodenum 16 and ileum 20. A first
endoscopic delivery device 30a is inserted orally and advanced through the esophagus
12, stomach 14, and into the duodenum 16. The endoscopic delivery device 30a consists
of a pre-assembled endoscope 32a, delivery catheter 34a, and magnetic implant 36a.
The magnetic implant 36a is releasably attached to the distal tip of the delivery
catheter 34a which has been assembled into a working channel of the endoscope 32a.
[0034] A second endoscopic delivery device 30b is inserted through the anus 22f, advanced
into the ascending colon 22a, and further advanced into the ileum 20. In similar fashion,
the endoscopic delivery device 30b consists of a pre-assembled endoscope 32b, delivery
catheter 34b, and magnetic implant 36b. The magnetic implant 36b is releasably attached
to the distal tip of the delivery catheter 34b which has been loaded into a working
channel of the endoscope 32b.
[0035] The rough position of the magnetic implants 36a and 36b and vessels 16 and 20 are
respectively confirmed and finely positioned using the same method as described previously.
Fig. 8 shows the magnetic implants 36a and 36b coupled together after the vessels
are positioned appropriately according to the previously described method. Fig. 9
shows the magnetic implants 36a and 36b after they have been released from the delivery
catheters 34a and 34b. The magnetic implants apply force for a period of time sufficient
for pressure necrosis to create the anastomosis. Fig. 10 illustrates the anastomosis
after the magnetic implants 36a and 36b have detached from the surrounding tissue
and are about to start their journey out of the digestive tract. Fig. 10 also shows
the preferable path the magnetic implants take to be eliminated from the digestive
tract. No permanent implant is left in the body. Although not ideal, the magnetic
devices may start their journey by traveling down the duodenum instead of the ileum
side of the anastomosis. This may take longer for the implants to exit the body as
they are taking a longer pathway. It is also contemplated that if they initially started
down the duodenum (long path) that once they reach the ileum side of the anastomosis
that they could pass through the anastomosis and travel down the duodenum a second
time. As described previously, the anastomosis size may be subsequently altered in
a second procedure.
[0036] The devices used to deploy and create the anastomoses in the previously described
methods for creating a partial bypass between the duodenum and transverse colon and
duodenum to ileum will now be explained in greater detail. For simplicity, most of
the figures will only show one device in each figure, however, it is assumed that
a second, preferably nearly identical, device will be needed to create the anastomosis
as shown in the methods previously described for creating a duodenum to ileum or colon
anastomosis. The endoscope used in the embodiments may be different if deploying a
magnetic implant in the upper gastrointestinal tract such as the duodenum than an
implant deployed in the ileum or colon. For example, a gastroscope may be used with
the devices delivered into the duodenum and a colonoscope may be used with devices
delivered into the colon or ileum. Also, the magnet in the second device will be assembled
in the opposite polarity from the first so that the first and second implant attract
instead of repel each other. Although not an all inclusive list, many embodiments
will be described so that those skilled in the art will appreciate that variations
upon these embodiments are within the spirit of the invention.
[0037] Fig. 11a shows an embodiment of a device useable to carry out the methods described
previously, in that, the endoscopic delivery device 30 consists of a pre-assembled
endoscope 32, delivery catheter 34, and implant 36. The delivery catheter 34 is loaded
into the working channel 38 of the endoscope 32 and the implant 36 is releasably attached
to the distal end of the delivery catheter 34 using a snare 42 that is wrapped around
a knob feature 40 integral to the magnetic implant 36. The implant 36 is docked onto
the delivery catheter 34 by applying tension to the snare wire 42 relative to the
delivery catheter and locking the wire relative to the delivery catheter in a handle
set that would be positioned at the proximal end of the delivery catheter.
[0038] The implant 36 is used in conjunction with a second implant 36. The two implants
36 are attracted to each other magnetically, at least one of which being a magnet.
Hence, as used hereinafter when describing the remaining device embodiments, each
implant will be referred to as a magnetic implant. This is to be interpreted as meaning
the implant contains a magnet or an element that is attracted to a magnet and should
not be interpreted as being limited to only magnets.
[0039] Fig. 11b illustrates unlocking the snare wire 42 and releasing the magnetic implant
36. The snare 42 is preferably formed of braided stainless steel cable or nitinol
wire so that when the snare is unlocked to release the magnetic implant 36 it grows
to a pre-formed size so that it may be easily released from the knob 40. Once the
implants have been released, the snare may also be used to recapture the implant by
re-snaring the knob on the implant. Although an external means for releasably attaching
the implant to the delivery catheter using a knob feature has been shown, an implant
housing is contemplated with internal releasable attachment features. The implants
may be pulled apart by pulling on the delivery catheter. Once pulled apart, they may
be repositioned or removed from the body.
[0040] Fig. 12 shows a cross section of the distal portion of the endoscopic delivery device
30 in its locked condition. The magnetic implant 36 consists of a magnet 44 and housing
46. The housing consists of a top 48a and bottom 48b. The top 48a contains a knob
feature 40 for holding onto the magnetic implant 36 with a snare 42. The magnetic
implant incorporates rounded atraumatic features for ease of tracking the device through
the body lumen prior to coupling and after the anastomosis has been created when the
magnetic device/implant is exiting the body. The magnetic implant is preferably longer
than it is wide and attached to the delivery catheter 34 so that the length is axially
aligned with the endoscope 32. This small profile of the device relative to the profile
of an endoscope aids in tracking the device ahead of the endoscope and allows variable
length devices to be used depending on the size of anastomosis required. Additionally,
the alignment of the magnetic implant aids in creating a side-to-side implant coupling
and resulting anastomosis between vessels that are in close proximity or adjacent
and aligned as shown in Fig. 15.
[0041] Figs. 13-15 illustrate the movement and flexibility of the delivery catheter 34.
The delivery catheter may move axially and be rotated relative to the endoscope 32.
Having the ability to telescope out of the endoscope and rotate the magnetic implant
36 may allow the operator ease of accessing the target locations within the body as
well as finely positioning the vessels and magnetic implants both axially and radially
for coupling. As shown in Fig. 15, in this embodiment the delivery catheter 34a and
attached magnetic implant 36a lead the endoscope 32a as it is tracked through the
body vessel. Therefore, it may be advantageous if the distal tip of the delivery catheter
is steerable to aid in tracking of the devices through the digestive tract. Fig. 13
shows a delivery catheter which articulates the magnetic implant in one direction
while Fig. 14 shows a delivery catheter that articulates approximately orthogonal
to the direction shown in Fig. 13. The catheter may be fabricated to have no articulation,
or articulation in one direction, or articulation in the orthogonal direction, or
both. The delivery catheter 34 preferably has excellent torsional stiffness so that
it can rotate the magnetic implant 36 yet is flexible enough to allow the implants
to easily attract and couple together.
[0042] For example, Fig. 15 shows two magnetic implants 36a and 36b coupled together in
adjacent vessels. The figure shows that the axes of the endoscopes 32a and 32b are
not aligned with the axis of the magnetic implants 36a and 36b. This is possible because
the delivery catheters 34a and 34b are flexible and conform to the coupled magnetic
implants 36a and 36b. The torsional stiffness and flexibility of the delivery catheter
34 may aid the operator with aligning and coupling the magnetic implants 36 so that
the more rigid endoscopes do not have to be perfectly aligned in order for the magnetic
implants 36a and 36b to couple. However, the flexibility of the endoscopes may be
adequate to aid in coupling of the magnetic implants 36 and it may not be necessary
to have a flexible catheter 34 to aid in coupling. The delivery catheters 34 preferably
have good tensile strength so that they can easily pull the magnetic implants 36 apart
should they need to be repositioned or removed. The delivery catheters 34 are preferably
formed using standard component guide catheter techniques and may be constructed of
a lamination of a Teflon liner, a high density stainless steel braid, and a polymer
outer jacket. The delivery catheter may be coated with a lubricious coating to aid
in advancing down the lumen of the endoscope and in the body vessel. Also, the implant
may be coated with a lubricious coating to aid in advancing through the body vessel.
The coating may be a silicone or hydrophilic coating.
[0043] Since the size of the anastomosis may affect the results of the partial bypass on
weight loss or diabetes resolution, it is advantageous that a wide range of magnetic
implant sizes are available to meet the needs of the range of sizes of human vessel
anatomy. One aspect of the invention is that the resulting anastomosis size and shape
is governed by the magnetic implant circumference and not necessarily its shape. As
shown in Fig 25 for example, if an anastomosis size of approximately 1.5" diameter
was required, the operator could implant a round magnet 50 with a 1.5" diameter and
a resulting approximately round anastomosis 52 of 1.5" diameter would result after
healing was complete. However, tracking a round magnet 50 that was not collapsible
through the digestive system would prove difficult as most endoscope diameters are
approximately 0.5 inches by comparison. Alternatively, an approximately 1.85" long
x 0.375" wide magnet 54 of equal circumference to the round magnet 50 could easily
be tracked through the digestive system if the long end of the magnet was aligned
and advanced axially ahead of the endoscope. This implant would also create an approximately
round anastomosis 56 of 1.5" diameter after healing was complete because even though
the coupled magnetic implants will create a necrotic core of tissue the same size
and shape as the magnets, the body over time remodels the shape of the implant to
the native vessel shape which is approximately round. Hence, as the circumference
of an elongate, relatively rectangular magnet having a width (w) and a length (I)
= 2(w) + 2(I), and the circumference of a relatively round anastomosis has a circumference
= 2Πr. Therefore for a given desired implant width (w), the implant length (I) required
to make an anastomosis having a desired radius (r) becomes Πr - w. With this in mind,
typical endoscope working channels range in inner diameter from 1.5mm to 7mm. Thus,
the magnetic implant widths (w) preferably fall within this range and, given the application
discussed herein, and the most common endoscopes on the market, more preferably fall
within the range of 1.5mm to 3.7mm.
[0044] Returning to Fig. 12, the magnet 44 is preferably a neodymium rare earth magnet.
The magnetic poles are aligned through the thickness of the magnet so that the maximum
magnetic force is achieved when the magnetic implants 36a and 36b are coupled as shown
in Fig. 15. The bottom of the housing 48b can be smooth or have a surface roughness
as the magnetic implants will align in either case because the inner lining of the
vessels are very lubricious. Although lubricious, a rough surface on the bottom of
the housing 48b may be advantageous once the magnets are coupled to prevent them from
decoupling due to shear forces. The magnetic implant 36 may contain one magnet as
shown in Fig. 12 or multiple smaller magnets . The housing 46 may be larger than the
magnet 44 to distribute the magnetic force over a larger area. The housing 46 may
be formed out of metal such as stainless steel, titanium, or other medical implant
grade metals. Alternatively, the housing may be made of silicone or other medical
implant grade polymers. Sections of the housing may be made out of biodegradable material.
For instance, the knob 40 may be overmolded with biodegradable material onto the housing
so that the knob would biodegrade after the magnetic implants are coupled. This would
create a smaller profile of the coupled magnetic implants and may be easier to pass
through the body once the anastomosis is created. The housing 46 may be formed of
a top 48a and bottom 48b piece as shown or may be one integral body if formed using
molding techniques. The housing's main functions are to provide a protective coating
around the magnetic so that is does not corrode should it crack or fracture, provide
attachment means to hold onto the magnet, distribute the force of a magnet over a
surface area, and provide an atraumatic surface that passes easily through the digestive
system. Although not preferred, a magnetically attracted ferrous metal core may take
the place of the magnets in one of the magnetic implants. For instance, using Fig.
15 as a reference, the magnetic implant 36a may contain a neodymium magnet 44a while
the second implant 36b may contain a magnetically attracted ferrous metal core instead
of a neodymium magnet 44b as shown in Fig. 15. The ferrous metal core would preferably
be the same size and shape as the neodymium magnet it replaces.
[0045] Figs. 16a-16c show an alternative embodiment of an endoscopic delivery device 130
used according to the methods described previously to create a duodenum to transverse
colon or ileum anastomosis. This embodiment is similar to the previous embodiment
except that the magnetic implant geometry has changed to allow the implant to attach
to the side of the endoscope while accessing the target anastomosis location. Fig.
16a shows a magnetic implant 136 docked to the end of an endoscope 132. The mafority
of the magnetic implant is long and thin except for the distal tip which contains
a knob 140 similar to the previous embodiment. Most of the length of the magnetic
implant resides on the side of the endoscope except for the leading edge containing
the knob. As compared to the previous embodiment where the implant was completely
in front of the scope, placing the implant in this position may allow the operator
a better field of view as the implant cannot be blocking the view while gaining access
to the target anastomosis location. However, the disadvantage is that the implant
will increase the overall profile of the endoscope making it potentially more difficult
to push through narrow regions such as the pylorus or ileocecal valve. A retention
feature 158 may be attached to the outside of the endoscope 132 to prevent the proximal
end of the implant 136 from bending away from the endoscope during retrograde movement
of the endoscope. For instance, the proximal end of the implant may catch on the vessel
wall or other anatomical features during retrograde movement. Similar to the previous
embodiment, Fig. 16b illustrates that the implant 136 can be moved axially from the
distal tip of the endoscope 132 Likewise, the endoscope is pre-assembled in similar
fashion to the previous embodiment in that a delivery catheter 134 is loaded into
the working channel 138 of the endoscope 132 and the magnetic implant 136 is releasably
attached to the distal end of the delivery catheter 34 using a snare 142 that is wrapped
around a knob feature 140 integral to the magnetic implant 36. Fig. 16c illustrates
unlocking the snare wire 142 and releasing the magnetic implant 136.
[0046] Fig. 17 shows a cross section of the distal portion of the endoscopic delivery device
130 in its locked condition. Similar to the previous embodiment, the magnetic implant
136 consists of a magnet 144 and housing 146. The housing consists of a top 148a and
bottom 148b. The top 148a contains a knob feature 140 for holding onto the magnetic
implant 136 with a snare 142. Although an external means for releasably attaching
the implant to the delivery catheter using a knob feature has been shown, an implant
housing is contemplated with internal releasable attachment features . As previously
described, the magnetic implant incorporates rounded atraumatic features for ease
of tracking the device through the body lumen prior to coupling and after the anastomosis
has been created when the implant is exiting the body.
[0047] Figs. 18a-18c show an alternative embodiment of an endoscopic delivery device 230
used according to the methods described previously to create a duodenum to transverse
colon or ileum anastomosis. This embodiment is similar to the previous embodiments
except that the magnetic implant geometry has changed to allow the implant to travel
down the working channel of an endoscope instead of being pre-assembled at the distal
end of the endoscope. One advantage of this embodiment as compared to the previous
embodiments is that the endoscope may access the target anastomosis site in the duodenum
and ileum or transverse colon without the potential challenges of the delivery catheter
or magnetic implant extending out of the distal tip of the endoscope or to the side
of the endoscope. This may allow the operator to use the endoscopes without the magnetic
implant potentially obstructing the view, or adding to the effective diameter of the
delivery device by the implant riding on the side of the scope, or adding to the overall
stiffness of the endoscope by having a delivery catheter in the working channel and
an implant leading the endoscope as the operator attempts to articulate the distal
end of the scope and navigate through the vessels. Preferably, the endoscope is advanced
through the vessel to the target implant location and the magnetic implant is subsequently
advanced through the working channel to the distal tip of the endoscope. However advantageous
it may seem to advance the delivery catheter and magnetic implant to the distal end
of the endoscope after it has reached its target location as just described, the operator
may pre-load the working channel with the delivery catheter and magnetic implant and
advance it to the distal tip of the endoscope prior to or while tracking the endoscope
through the body vessel to the target anastomosis location. Although the previously
described embodiments may also work with advanced access tools, this embodiment is
more readily available to be used with single of double balloon enteroscopes or other
overtube or externally applied devices to a standard endoscope for gaining access
deep into the small bowel from either a nasal, oral, or anal access location.
[0048] Fig.18a illustrates that once the endoscope is navigated to the target anastomosis
location, the magnetic implant 236 has been introduced into the endoscope 232 and
advanced axially within the working channel 238 to the tip of the endoscope. Fig.
18b shows the implant 236 fully advanced out the endoscope 232 in a position for coupling.
The implant is attached to the delivery catheter 234 by pulling a loop feature 260
attached to the implant into the lumen of the delivery catheter using a grabber 242
that resides within the lumen of the delivery catheter. Fig. 19. shows a detailed
view of the connection of the magnetic implant 236 to the distal end of the delivery
catheter 234. The loop 260 is back-loaded into the delivery catheter 234 by inserting
the loop in the U-shaped jaw of the grabber 242 and pulling the grabber and loop into
the delivery catheter. The height of the u-shaped feature is approximately the same
size as the inner diameter of the delivery catheter so that the loop is trapped between
the u-shaped jaw and the inner wall of the catheter. After the loop is pulled into
the delivery catheter, the grabber is pulled tight relative to the delivery catheter
and locked in a handle set (not shown) that would be positioned at the proximal end
of the delivery catheter. While pulling tight, the implant 236 is rotated so the teeth
262 on the distal end of the delivery catheter 234 mate and insert into the notch
264 on the implant. The teeth transfer torque and rotation of the delivery catheter
to the implant while the grabber 242 couples the implant axially to the catheter.
These features allow the implant to be advanced axially and rotated relative to the
endoscope to aid with fine positioning of the implant prior to and during coupling.
[0049] Fig. 18c shows the implant 236 released from the delivery catheter 234. The grabber
242 is advanced distally relative to the delivery catheter so that the loop 260 is
able to leave the U-shaped jaw of the grabber. Fig. 20. shows a detailed view of the
distal end of the delivery catheter and proximal end of the magnetic implant after
release. Similar to the previous embodiments after release, the grabber 242 may recapture
the loop 260 if the implant 236 needs to be repositioned or removed from the body.
Although an external means for releasably attaching the implant to the delivery catheter
using a loop feature has been shown, an implant housing is contemplated with internal
releasable attachment features .
[0050] Fig. 21 shows the distal end of the endoscopic delivery device 230 in various cross
sections. Section C-C shows the width of the magnets while Section D-D shows the thickness.
Fig. 22 illustrates that the magnetic implant 236 is flexible so that it may be easily
tracked through a flexible endoscope 232. The implant may consist of one magnet or
several depending on the overall length of the desired implant and the flexibility
needed to access the target anastomosis location. The housing 246 may be constructed
of an implant grade polymer of a durometer (hardness) that allows it to bend as shown.
It may be fabricated and assembled by starting with an extrusion and assembling the
magnets into the extrusion, or the magnets may be insert molded. If insert molded,
the polymer used should have melt temperature that does not degrade the magnetic properties
of the magnet. The housing may also be fabricated out of an implant grade metal if
the implant itself does not need to be flexible; however, it can be envisioned that
a series of individual magnet are encapsulated in a metal housing could be attached
in series with a cable, ribbon, or hitch feature coupling them all together where
the ribbon or cable flexed so that the train of magnets could navigate a tortuous
path. The ribbon or cable linking the series of magnets would preferably transfer
rotational and axial movement from a releasably attached delivery catheter. As previously
described, the implant incorporates rounded atraumatic features for ease of tracking
the device into the body lumen prior to coupling and after the anastomosis has been
created when the implant is exiting the body. The implant may be coated with a lubricious
coating to aid in tracking down the lumen of the endoscope. Similar to the previous
embodiments, the magnets are preferably neodymium rare earth magnets. The notched
collar 264 and loop 260 may be insert molded into the housing or separately attached
by reflowing them into the polymer of the housing or bonding them to the housing.
The collar may be integrated into the housing instead of a separate component. The
loop may be fabricated out of implant grade braided wire, solid wire, or nitinol wire.
It may also be fabricated out of implant grade monofilament or braided polymer line.
[0051] Fig. 23a shows an alternative attachment device for grabbing the loop 260 on the
magnetic implant 236. In this figure, a mechanically actuated jaw grabber 266 is used
to grab the loop instead of the grabber 242 shown in previous figures. The grabber
has a slot cut through it to accept the loop. Similarly, the grabber 266 pulls the
loop into the delivery catheter 234 and the teeth 262 slide into the slot 264 on the
implant to transfer the torque as previously described. Fig. 23b shows the implant
236 released from the jaws of the grabber 242.
[0052] Figs. 24a-24c show another variation of the previously described embodiment. This
embodiment shows a different delivery catheter 334 with different releasable attachment
features on the proximal end of the magnetic implant 336. This is to illustrate that
there are many variations on how to releasably attach a thin magnetic implant that
slides down the working channel of an endoscope to a delivery catheter. Those skilled
in the art will appreciate that any deviations from what is shown would be encompassed
in the spirit of the present invention. The difference in this variation is that the
mechanically actuated jaw 366 is permanently attached to the distal tip of the delivery
catheter 334 and does not slide within the lumen of the catheter. The torque transmitting
teeth 262 and slot 264 from the previous embodiment have been replaced with a slot
372 feature in the mechanically actuated jaw and a mating bar 370 feature integrated
into the housing 346 of the magnetic implant 336, respectively. The ball 368 feature
integrated into the housing 346 transmits axially movement of the catheter 334 to
the implant 336. Fig. 25 shows a detailed view of the distal tip of the catheter 334
and the proximal end of the magnetic implant 336. The slot 372 in the mechanically
actuated jaw 366 is sized to mate and transmit torque to the bar 370 in the housing
of the magnetic implant 336. The ball 368 and bar 370 may be bonded, molded, insert
molded, or over molded onto the housing. Although an external means for releasably
attaching the implant to the delivery catheter using a ball and bar feature have been
shown, an implant housing is contemplated with internal releasable attachment features
[0053] Since endoscopes have a wide range of working channel diameters. It may be advantageous
to use a scope with a rather small working channel. This may translate into using
a small magnetic implant that might not have enough strength to overcome the daily
loads that the intestinal vessels experience from natural digestive processes and
outside physical loads, therefore one magnetic implant may not give enough force or
area to ideally create the desired anastomosis or maintain implant coupling due to
internal or external loads. One aspect of the present invention is that multiple magnetic
implants may be used to increase the strength and/or area of the anastomotic implant(s)
in each vessel. Fig. 26 shows that the magnetic implants of the previously and subsequently
described embodiments and variations may incorporate a second magnetic implant deployed
to the side of the first implant to increase the anastomosis area and overall force
clamping the vessels together at the anastomosis site. Fig. 27 shows a scenario where
another magnetic implant 236 or 336 is stacked on top of a previously deployed magnetic
implant 236 or 336 in the same vessel. This would double the force applied to create
the anastomosis over the same area, therefore doubling the pressure on the trapped
tissue. Fig. 28 shows a scenario where magnetic implants 236 or 336 have been stacked
to the side and on top of previously applied magnetic implants. Magnetic implants
may also be stacked in line (in front or behind) so that shorter implants could be
placed in line to create a longer effective implant . The figures in no way illustrate
all the combinations that those skilled in the art could easily contemplate.
[0054] Figs. 29a-29d show in stepwise fashion an embodiment of an endoscopic delivery device
deploying a magnetic implant from an overtube assembled to the outside of an endoscope.
The endoscopic delivery device 430 consists of a magnetic implant 436 releasably attached
to a delivery catheter 434 that axially and rotationally moves within a lumen in the
wall of an overtube 474. The overtube, delivery catheter, and magnetic implant assembly
are back-loaded onto the endoscope 432 prior to inserting into the body. This view
shows the overtube 474 in a retracted position away from the distal tip of the endoscope
432 allowing the articulating portion of the endoscope to be free from constrainment
of the overtube. This feature allows the operator the ability to freely navigate through
the body vessels without view obstruction of the magnetic implant 436 or hindrance
of articulation of the endoscope. A grasping device 478 releasably holds the magnet
in a slot 476 on the overtube 474. The notch on the overtube provides further constrainment
of the magnet, especially in transferring torque and rotation to the implant about
the endoscope. Fig. 29b illustrates that the overtube 474 can be moved axially in
relation to the endoscope 432. Once the operator has navigated the distal tip of the
endoscope to the desired target anastomosis location, the magnetic implant 436 is
advanced to the tip of the endoscope 432 by moving the overtube 474 axially as shown.
The ability to rotate the overtube about the endoscope allows the operator to position
the implant in any radial direction to aid in achieving magnetic coupling with another
magnetic implant in an adjacent vessel. Fig. 29c illustrates the delivery catheter
434 telescoping the magnetic implant 436 distal to the tip of the endoscope 432 to
aid in magnetic coupling to another implant in an adjacent vessel. Also, the implant
may be radially aligned by rotating the shaft of the delivery catheter. Fig. 29d shows
the overtube 474, delivery catheter 434, and mechanically actuated jaw grabber 466
after the magnetic implant 436 has been released. The mechanically actuated jaw grabber
466 is attached to the delivery catheter 434. The delivery catheter 434 is located
within a lumen 478 in the wall of the overtube 474. The mechanically actuated grabber
may be designed to releasably attach to a feature that is internal or external to
the magnetic implant . As described in the previous embodiments, the delivery catheter
may be coated with a lubricious coating to aid in advancing down the lumen of the
overtube. The inner diameter of the overtube may be coated to aid in advancing and
rotating the overtube about the endoscope. Also, the implant may be coated with a
lubricious coating to aid in advancing through the body vessel. The coating may be
a silicone or hydrophilic coating.
[0055] Figs. 30a-30c show in stepwise fashion an alternative embodiment of an overtube endoscopic
delivery device similar to the device previously described. This embodiment shows
an overtube with a slot formed in the distal tip to receive a small profile magnetic
implant as previously described in Figs. 18-25. The overtube also has a lumen within
its wall to accept a delivery catheter as previously described. The endoscopic delivery
device 530 consists of a magnetic implant 536 releasably attached to a delivery catheter
534 that axially and rotationally moves within a lumen 578 in the wall of an overtube
574. Similar to the previous embodiment, the overtube, delivery catheter, and magnetic
implant assembly are back-loaded onto the endoscope 532 prior to inserting into the
body. Fig. 30a shows the overtube 574 in a retracted position away from the distal
tip of the endoscope 532 allowing the articulating portion of the endoscope to be
free from constrainment. The overtube 574 may be designed to integrate with any endoscope;
however, the endoscope is preferably a gastroscope, colonoscope, or small diameter
enteroscope.. The distal end of the overtube is tapered to transition to the outer
diameter of the endoscope. A balloon 580 may or may not be incorporated at the tip
of the overtube 574 to allow single or double enteroscopy to aid in accessing target
anastomosis locations deep with the bowel. As previously described in the embodiments,
features within the delivery catheter and on the magnetic implant releasably attach
the implant to the delivery catheter. The delivery catheter 532 holds the implant
within the slot 576 of the overtube 574. As previously described, the slot on the
overtube provides further constrainment of the magnetic implant, especially in transferring
torque and rotation to the implant about the endoscope. Likewise, Fig. 30b illustrates
the delivery catheter 534 telescoping the magnetic implant 536 distal to the tip of
the endoscope 532 to aid in magnetic coupling to another implant in an adjacent vessel.
Also, the implant may be radially aligned by rotating the shaft of the delivery catheter.
Fig. 30c shows the delivery catheter 534 and grabber 542 after the magnetic implant
436 has been released. The delivery catheter, grabber and attachment features on the
implant are for illustrative purposes as any combination of delivery catheter, grabber,
and implant releasable attachment feature described in the previous embodiments may
be incorporated as appropriate.
[0056] Figs. 31a-31c show in stepwise fashion a variation of the previously described embodiment
as shown in Fig. 30a-30c. The variation is different in that the slot or channel extends
the entire length of the overtube instead of only at the distal tip of the overtube.
Also, the channel is entirely within the wall of the lumen which allows the magnetic
implant to be tracked along the entire length of the overtube. Similar to the previous
embodiment, the overtube is back-loaded onto the endoscope 532 prior to inserting
into the body, but the delivery catheter and magnetic implant may be loaded in the
channel prior to inserting into the body. It may be easier to articulate the endoscope
and navigate to the target anastomosis location without the increased stiffness of
the magnetic implant and delivery catheter near the distal tip of the endoscope; therefore,
it may be preferable to advance the implant and catheter after the target location
is reached. However, it may not be necessary and may be preferable in some cases to
telescope out of the distal tip to help introduce/guide the endoscope through the
anatomy. Since the catheter and magnetic implant may be freely exchanged through the
channel, the operator may deploy a second or multiple magnetic implants at the target
location without removing the endoscopes from the target location. Fig. 31a shows
the overtube 574 in a retracted position away from the distal tip of the endoscope
532. Fig. 31b illustrates the delivery catheter 534 telescoping the magnetic implant
536 distal to the tip of the endoscope 532 through the channel 582 in the overtube
574. Fig. 31c shows the variation after the magnetic implant has been released. As
described in the previous embodiments, the delivery catheter may be coated with a
lubricious coating to aid in advancing down the channel of the overtube. The inner
diameter of the overtube may be coated to aid in advancing and rotating the overtube
about the endoscope. Also, the implant may be coated with a lubricious coating to
aid in advancing through the channel of the overtube. The coating may be a silicone
or hydrophilic coating.
[0057] Athough not preferred, another aspect of the invention for all the overtube embodiments
is that the full profile of the overtube could be shorter and reside at the distal
tip of the endoscope and not extend its full profile proximally out of the body. Instead,
a smaller overtube profile just encompassing the delivery catheter could extend from
the short, full profile section at the distal end of the endoscope proximally out
of the body. Or, the overtube may only consist of a short, full profile at the distal
tip of the endoscope with only the delivery catheter extending proximally out of the
body.
[0058] Although the invention has been described in terms of particular embodiments and
applications, one of ordinary skill in the art, in light of this teaching, can generate
additional embodiments and modifications without departing from the spirit of or exceeding
the scope of the claimed invention. For example, though the devices described herein
are optimally designed for use in a probe, obviating the need for puncturing patient
tissue or making incisions, one skilled in the art will appreciate that these devices
could be used in surgical or laparoscopic procedures. Accordingly, it is to be understood
that the drawings and descriptions herein are proffered by way of example to facilitate
comprehension of the invention and should not be construed to limit the scope thereof.
Examples of the disclosure include:
[0059]
- 1. A method of creating an anastomosis comprising:
navigating a first probe through the digestive tract of a patient via the esophagus
to a first target location in the duodenum of the patient;
navigating a second probe through the digestive tract of the patient via the rectum
to a second target location in the bowel, naturally adjacent to the duodenum;
establishing, without puncturing patient tissue, a magnetic connection between a first
anastomosis-forming device carried by the first probe and a second anastomosis-forming
device carried by the second probe;
releasing said first and second devices from said first and second probes.
- 2. The method of example 1 wherein navigating a first probe through the digestive
tract of a patient via the esophagus to a first location in the duodenum of the patient
comprises navigating a first endoscope through the digestive tract of a patient via
the esophagus to a first target location in the duodenum of the patient.
- 3. The method of example 1 wherein navigating a second probe through the digestive
tract of the patient via the rectum to a second target location in the bowel, naturally
adjacent to the duodenum comprises navigating a second endoscope through the digestive
tract of the patient via the rectum to a second target location in the bowel, naturally
adjacent to the duodenum.
- 4. The method of example 1 wherein the first target location and second target location
are sufficiently naturally adjacent to allow said magnetic connection without manipulation
of either target location.
- 5. The method of example 1 wherein establishing, without puncturing patient tissue,
a magnetic connection between a first anastomosis-forming device carried by the first
probe and a second anastomosis-forming device carried by the second probe comprises
aligning said first anastomosis-forming device with said second anastomosis-forming
device using visual guidance.
- 6. The method of example 1 wherein establishing, without puncturing patient tissue,
a magnetic connection between a first anastomosis-forming device carried by the first
probe and a second anastomosis-forming device carried by the second probe comprises
aligning said first anastomosis-forming device with said second anastomosis-forming
device using fluoroscopic guidance.
- 7. A method of creating an anastomosis comprising:
navigating a first endoscope through the digestive tract of a patient via the esophagus
to a first target location in the duodenum of the patient;
navigating a second endoscope through the digestive tract of the patient via the rectum
to a second target location in the bowel, naturally adjacent to the duodenum;
advancing through a working channel of said first endoscope, a first elongate anastomosis-forming
device;
advancing through a working channel of said second endoscope, a second elongate anastomosis-forming
device;
establishing a magnetic connection between said first and second anastomosis-forming
devices;
releasing said first and second devices from said first and second endoscopes.
- 8. The method of example 7 wherein establishing a magnetic connection between said
first and second anastomosis forming devices comprises aligning said first and second
anastomosis forming devices across tissues from said duodenum and said bowel such
that a magnetic attraction occurs between said devices.
- 9. The method of example 8 wherein aligning said first and second anastomosis forming
devices across tissues from said duodenum and said bowel such that a magnetic attraction
occurs between said devices comprises visually aligning said first and second anastomosis
forming devices across tissues from said duodenum and said bowel such that a magnetic
attraction occurs between said devices.
- 10. The method of example 8 wherein aligning said first and second anastomosis forming
devices across tissues from said duodenum and said bowel such that a magnetic attraction
occurs between said devices comprises fluoroscopically aligning said first and second
anastomosis forming devices across tissues from said duodenum and said bowel such
that a magnetic attraction occurs between said devices.
- 11. A device for forming a substantially round anastomosis having a radius (r) comprising:
a first elongate component having a length (I) and a width (w); and,
a second elongate component magnetically attracted to said first component and having
a length (I) and a width (w);
wherein width (w) is narrow enough to fit within a working channel of a standard endoscope;
and,
wherein length (I) is related to a desired radius (r) of a resulting, substantially
round anastomosis according to the formula (I) = (Π)(r) - (w).
- 12. The device of example 11 wherein (w) is less than 7mm.
- 13. The device of example 12 wherein (w) is between 1.5mm and 7mm.
- 14. The device of example 13 wherein (w) is between 1.5mm and 3.7mm.
- 15. A system for forming an anastomosis in a digestive tract of a patient comprising:
first and second probes, each probe defining at least one lumen slidingly housing
an attachment mechanism and each probe having an optic lens;
a first device carried by said first probe and attached thereto by said attachment
mechanism, said first device comprising:
a magnet;
a housing at least partially encasing said magnet, said housing defining a connector
releasably and repeatably engageable by said attachment mechanism;
a second device carried by said second probe and attached thereto by said attachment
mechanism, said second device comprising;
an element attracted to said magnet of said first device;
a housing at least partially encasing said element, said housing defining a connector
releasably and repeatably engageable by said attachment mechanism.
- 16. The system of example 15 wherein:
said first device has a length (I) and a width (w);
wherein width (w) is narrow enough to fit within a working channel of a standard endoscope;
and,
wherein length (I) is related to a desired radius (r) of a resulting, substantially
round anastomosis according to the formula (I) = (Π)(r) - (w).
- 17. The device of example 16 wherein (w) is less than 7mm.
- 18. The device of example 17 wherein (w) is between 1.5mm and 7mm.
- 19. The device of example 18 wherein (w) is between 1.5mm and 3.7mm.
- 20. The device of example 15 wherein said connector comprises a knob.
- 21. The device of example 15 wherein said connector comprises a loop.
- 22. A method of forming a round anastomosis comprising:
positioning two devices on either side of a desired anastomosis site such that tissue
is compressed between said two magnets;
wherein each of said devices comprises a single elongate magnet having a length that
is approximately half of a desired circumference of a resulting anastomosis;
wherein each of said devices has a width of less than 7mm.
- 23. The method of example 22 wherein each of said devices has a width in the range
of 1.5mm to 7mm.
- 24. The method of example 22 wherein each of said devices has a width in the range
of 1.5mm to 3.7mm.
1. A system for forming an anastomosis in a digestive tract of a patient comprising:
first and second probes (32a, 32b), each probe (32a, 32b) defining at least one lumen
slidingly housing an attachment mechanism (42, 242, 266) and each probe (32a, 32b)
having an optic lens;
a first device carried by the first probe (32a) and attached thereto by the attachment
mechanism (42, 242, 266), the first device comprising:
a magnet (44a);
a housing (46a) at least partially encasing the magnet (44a), the housing defining
a connector (40, 260, 264) releasably and repeatably engageable by the attachment
mechanism (42, 242, 266); and
a second device carried by the second probe (32b) and attached thereto by the attachment
mechanism (42, 242, 266), the second device comprising:
an element (44b) attracted to the magnet (44a) of the first device; and
a housing (46b) at least partially encasing the element (44b), the housing (46b) defining
a connector (40, 260, 264) releasably and repeatably engageable by the attachment
mechanism (42, 242, 266).
2. The system of claim 1, wherein:
the first device has a length (I) and a width (w);
wherein the width (w) is narrow enough to fit within a working channel of the first
probe (32a) or the second probe (32b); and
wherein the length (I) is related to a desired radius (r) of a resulting, substantially
round anastomosis according to the formula (I) = (π)(r) - (w) as the body over time
remodels the shape of the necrotic core tissue created by the implanted elongate components
to the native vessel shape which is approximately round.
3. The system of claim 2, wherein (w) is less than 7mm.
4. The system of claim 3, wherein (w) is between 1.5mm and 7mm.
5. The system of claim 4, wherein (w) is between 1.5mm and 3.7mm.
6. The system of claim 1, wherein the connector of the housing (46) of the first device
or the housing (46) of the second device comprises a knob (40).
7. The system of claim 6, wherein the knob (40) is overmolded with a biodegradable material
onto the housing (46).
8. The system of claim 1, wherein the connector comprises a loop (260).
9. The system of claim 8, wherein the loop (260) is fabricated out of implant grade braided
wire, an implant grade solid wire or an implant grade nitinol wire.
10. The system of claim 8, wherein the loop (260) is fabricated out of implant grade monofilament
or braided polymer line.
11. The system of claim 1, wherein the housing (46) of the first device or the housing
(46) of the second device is formed out of stainless steel or titanium.
12. The system of claim 1, wherein the housing (46) of the first device or the housing
(46) of the second device is made of silicone.
13. The system of claim 1, wherein the first device or the second device incorporates
rounded atraumatic features.
14. The system of claim 1, wherein the first device or the second device is configured
for use with a laparoscopic procedure.
15. The system of claim 1, wherein the magnet (44a) comprises a plurality of magnets (244)
flexibly connected in series to form a flexible magnetic implant (236a).